Patent Assignment
Reel/Frame 046986/0674
Change of Name
Recorded: 2018-08-30
Pages: 3
Assignor
SYNTONIX PHARMACEUTICALS, INC.
Executed: 2010-05-19
Assignee
BIOGEN IDEC HEMOPHILIA INC.
9 FOURTH AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Application:
15/866,203 →
Publication:
US 2018/0237762
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Aug 30, 2018
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 046986/0510 →
Change of Name
Aug 30, 2018
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 046986/0546 →
Change of Address
Aug 30, 2018
From: BIOGEN HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 046986/0653 →
Assignment of Assignor's Interest
Aug 30, 2018
From: RIVERA, DANIEL S.; PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 046755/0896 →